SciELO - Scientific Electronic Library Online

vol.26 issue1Intraventricular hemorrhage in premature infants in a third level unit at México CityNeurodisability diagnosis in the neonatal period in Mexico, results of a survey of health personnel author indexsubject indexsearch form
Home Pagealphabetic serial listing  

Services on Demand




Related links

  • Have no similar articlesSimilars in SciELO


Perinatología y reproducción humana

Print version ISSN 0187-5337


TABARES-TRUJILLO, María Katherine et al. Menopause syndrome: implications of hormone therapy. Perinatol. Reprod. Hum. [online]. 2012, vol.26, n.1, pp.26-29. ISSN 0187-5337.

Introduction: The incidence of cardiovascular disease and metabolic syndrome during the menopause is around 35%. The objective of this study was to establish the relation between anthropometric and biochemical values in those patients with metabolic syndrome with and without hormone replacement therapy during menopause. Methods: A retrospective cohort study with case analysis of the Coordination of Peri and Postmenopause at the Instituto Nacional de Perinatología Isidro Espinosa de los Reyes during the period between 1998 and 2009; the study included those patients with diagnosis of metabolic syndrome. The variables analyzed were: a) anthropometric, b) biochemical indicators and c) blood pressure levels, divided in two groups: patients with hormone replacement therapy (Group I) and patients without hormonal therapy (Group II). The statistical analysis were performed depending on the variable, with chi-square, Student t test and OR, CI (95%). Results: 310 cases were included: Group I, 121 cases and Group II 189 cases. There were no statistically significant differences on anthropometric and biochemical indicators, but significant differences in cholesterol (p=0.024) and diastolic blood pressure levels, were found (p <0.001) in patients receiving hormone replacement therapy. Group II had an OR 5.27, CI 95% (2-13.87) for diastolic blood pressure> 90 mmHg. Conclusions: Patients with metabolic syndrome without hormone replacement therapy have an increased risk for diastolic blood pressure > 90 mmHg and a tendency to maintain higher cholesterol levels and increasing the risk of developing cardiovascular disease, although research on the different risk factors, and the implications of hormone therapy, are still insufficient to recognize the scale of the problem in the climacteric woman.

Keywords : Metabolic syndrome; hormone therapy replacement; menopause.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )


Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License